Top 10 Companies in the Global Polyclonal Antibodies Market in 2026

Market Overview

The Global Polyclonal Antibodies Market is anticipated to register an 8.89% CAGR during 2026–2034. The market size was valued at USD 2.05 billion in 2026 and is projected to reach USD 4.05 billion by 2034. Rising demand for polyclonal antibodies in diagnostics, therapeutics, and life science research continues to accelerate market expansion. Growing investments in biopharmaceutical R&D and increasing adoption of antibody-based assays are key drivers shaping this competitive landscape.

Top 10 Polyclonal Antibodies Companies | Best Brands

1. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a global leader in serving science, offering a comprehensive portfolio of research reagents, instruments, and consumables. In the polyclonal antibodies segment, the company provides an extensive catalog of primary and secondary antibodies used across immunoassay, western blotting, and flow cytometry applications. Their Invitrogen and Pierce Antibody brands are widely recognized across academic, clinical, and industrial research settings worldwide. Thermo Fisher's robust manufacturing capabilities and global distribution network make it one of the most trusted suppliers in the polyclonal antibodies market.

2. Merck KGaA

Merck KGaA is one of the world's oldest science and technology companies, operating across healthcare, life science, and electronics segments. Through its MilliporeSigma division, Merck supplies a broad range of polyclonal antibodies and immunological reagents for research and clinical diagnostics. The company's antibody products are utilized in a wide variety of applications including ELISA, immunohistochemistry, and immunofluorescence. Merck KGaA maintains a strong global presence with research facilities and distribution centers serving laboratories across North America, Europe, and Asia-Pacific.

3. Abcam plc.

Abcam is a leading supplier of research-grade antibodies and life science tools, recognized for its rigorous product validation and quality assurance processes. The company offers thousands of polyclonal antibody products targeting a wide range of proteins, cytokines, and biomarkers across multiple species. Abcam's RabMAb and polyclonal rabbit antibody lines are particularly well-regarded in immunology and cancer research communities. With operations spanning the UK, USA, China, and Japan, Abcam serves a broad customer base of academic institutions, biotech firms, and pharmaceutical companies globally.

4. ProteoGenix

ProteoGenix is a specialized contract research organization focusing on custom antibody production and protein expression services. The company offers end-to-end polyclonal antibody development services, from antigen design and immunization to affinity purification and validation. ProteoGenix serves pharmaceutical, biotechnology, and academic research clients requiring highly specific, custom-generated polyclonal antibodies. Their state-of-the-art European facilities and competitive turnaround times have established them as a key player in the custom antibody services segment of the global market.

5. Proteintech Group Inc.

Proteintech Group is a life science company dedicated to producing high-quality antibodies and ELISA kits for biomedical research. The company manufactures all of its polyclonal antibodies in-house, ensuring consistent lot-to-lot quality and traceability for researchers. Proteintech's catalog includes over 15,000 antibodies covering virtually all human proteins, with strong applications in neuroscience, oncology, and cell biology. With offices in the USA, UK, Germany, and China, Proteintech has built a significant international presence in the global polyclonal antibodies supply chain.

6. Bio-Rad Laboratories Inc.

Bio-Rad Laboratories is a multinational manufacturer of life science research products and clinical diagnostic tools. In the polyclonal antibodies market, Bio-Rad offers a diverse selection of antibodies targeting proteins relevant to immunology, cell signaling, and infectious disease research. Their StarBright fluorescent secondary antibody range and a wide catalog of species-specific polyclonal antibodies are widely used in multiplex assay formats. Bio-Rad's global manufacturing infrastructure and longstanding reputation for quality make it a reliable partner for researchers and diagnostics developers worldwide.

7. BPS Bioscience Inc.

BPS Bioscience is a biotechnology company specializing in recombinant proteins, antibodies, and cell-based assay kits for drug discovery and life science research. The company provides polyclonal antibodies targeting epigenetic regulators, kinases, and other critical drug target proteins. BPS Bioscience's antibodies are particularly valued in the pharmaceutical and biotech industry for their role in assay development, target validation, and screening workflows. Their focused expertise in drug discovery-relevant biologics positions them as a niche but highly specialized contributor to the polyclonal antibodies market.

8. R&D Systems Inc.

R&D Systems, a Bio-Techne brand, is a globally recognized supplier of cytokines, growth factors, antibodies, and immunoassay kits for life science research. The company's polyclonal antibody portfolio is extensively used in cytokine detection, stem cell research, and inflammatory disease studies. R&D Systems places strong emphasis on antibody validation, offering extensive datasheets and peer-reviewed publication references for its products. Operating as part of the broader Bio-Techne group, R&D Systems benefits from a global distribution network that ensures product accessibility across major research markets worldwide.

9. Atlas Antibodies

Atlas Antibodies is a Swedish biotechnology company that originated from the Human Protein Atlas project, a landmark initiative to map all human proteins using antibody-based proteomics. The company specializes in highly validated polyclonal and recombinant antibodies for use in immunohistochemistry, western blotting, and immunofluorescence applications. Atlas Antibodies' products are supported by extensive validation data generated across multiple tissue types and cell lines, offering researchers a high degree of confidence in specificity. Their science-driven approach and commitment to reproducibility have earned them strong recognition among proteomics and pathology research communities globally.

10. Others

The global polyclonal antibodies market also includes a growing number of regional and emerging players that contribute significantly to overall market competition. Companies such as Sino Biological Inc., GenScript Biotech, Creative Diagnostics, and Jackson ImmunoResearch Laboratories serve important roles across Asia-Pacific, North America, and European markets. Domestic manufacturers in countries such as China, India, and South Korea are increasingly investing in antibody production capabilities to meet local research and diagnostics demand. As the market continues to expand through 2034, competitive intensity is expected to increase, driving further innovation, price optimization, and strategic collaborations across the supply chain.

This blog is based on market research data and publicly available company information. For the most up-to-date statistics, refer to the latest reports from The Report Cube.